Received Nov 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUBLOK) | SANOFI PASTEUR | UNK | U8832CA | OT |
expiration date for a FLUBLOK vaccine given to a patient back in September, with no reported adverse event; Initial information received on 03-Nov-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a patient with unknown age and gender who was given Influenza Trivalent Recombinant Vaccine [Flublok] and expiration date was back in september, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date in Sep-2025, the patient received an unknown dose of suspect Influenza Trivalent Recombinant Vaccine, Solution for injection (lot U8832CA, expiry date and strength not reported) via unknown route in unknown administration site for Immunisation and expiration date for a flublok vaccine given to a patient back in september, with no reported adverse event (expired product administered) (latency same day). Reportedly, due to caller having an unknown issue with expiration documentation of a dose of Flublok thus having the pharmacist seeking the correct information. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.